OrthoPediatrics (KIDS) Competitors $27.36 +0.83 (+3.13%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KIDS vs. ATRI, CSII, TCMD, OSUR, CERS, ENOV, IRTC, SLNO, CNMD, and TNDMShould you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Atrion (ATRI), Cardiovascular Systems (CSII), Tactile Systems Technology (TCMD), OraSure Technologies (OSUR), Cerus (CERS), Enovis (ENOV), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), CONMED (CNMD), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical" sector. OrthoPediatrics vs. Atrion Cardiovascular Systems Tactile Systems Technology OraSure Technologies Cerus Enovis iRhythm Technologies Soleno Therapeutics CONMED Tandem Diabetes Care OrthoPediatrics (NASDAQ:KIDS) and Atrion (NASDAQ:ATRI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Which has more risk and volatility, KIDS or ATRI? OrthoPediatrics has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Atrion has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Do insiders and institutionals hold more shares of KIDS or ATRI? 69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 66.2% of Atrion shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by insiders. Comparatively, 22.8% of Atrion shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings & valuation, KIDS or ATRI? Atrion has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthoPediatrics$175.07M3.78-$20.97M-$1.09-25.10Atrion$181.60M4.46$19.41M$10.6443.23 Is KIDS or ATRI more profitable? Atrion has a net margin of 10.60% compared to OrthoPediatrics' net margin of -14.35%. Atrion's return on equity of 7.75% beat OrthoPediatrics' return on equity.Company Net Margins Return on Equity Return on Assets OrthoPediatrics-14.35% -5.44% -4.67% Atrion 10.60%7.75%7.12% Does the MarketBeat Community prefer KIDS or ATRI? OrthoPediatrics received 180 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.24% of users gave OrthoPediatrics an outperform vote while only 50.79% of users gave Atrion an outperform vote. CompanyUnderperformOutperformOrthoPediatricsOutperform Votes30964.24% Underperform Votes17235.76% AtrionOutperform Votes12950.79% Underperform Votes12549.21% Do analysts prefer KIDS or ATRI? OrthoPediatrics presently has a consensus target price of $40.00, indicating a potential upside of 46.20%. Given OrthoPediatrics' higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than Atrion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OrthoPediatrics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Atrion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media prefer KIDS or ATRI? In the previous week, OrthoPediatrics had 2 more articles in the media than Atrion. MarketBeat recorded 2 mentions for OrthoPediatrics and 0 mentions for Atrion. OrthoPediatrics' average media sentiment score of 0.00 equaled Atrion'saverage media sentiment score. Company Overall Sentiment OrthoPediatrics Neutral Atrion Neutral SummaryOrthoPediatrics and Atrion tied by winning 8 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get OrthoPediatrics News Delivered to You Automatically Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KIDS vs. The Competition Export to ExcelMetricOrthoPediatricsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$662.50M$4.45B$5.39B$8.53BDividend YieldN/A42.37%5.13%4.14%P/E Ratio-25.1038.29113.8115.12Price / Sales3.7865.071,483.2593.03Price / CashN/A49.1039.6434.05Price / Book1.704.264.665.02Net Income-$20.97M$11.52M$119.06M$225.46M7 Day Performance6.50%1.05%0.79%0.37%1 Month Performance5.76%0.94%5.65%3.57%1 Year Performance6.13%39.40%36.76%29.42% OrthoPediatrics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KIDSOrthoPediatrics4.0912 of 5 stars$27.36+3.1%$40.00+46.2%+11.1%$662.50M$175.07M-25.10200Upcoming EarningsATRIAtrionN/A$459.92flatN/AN/A$809.46M$181.60M43.23720Upcoming EarningsAnalyst ForecastCSIICardiovascular Systems0.6365 of 5 stars$20.00flatN/A+0.0%$843.96M$239.84M-20.62780Analyst ForecastTCMDTactile Systems Technology2.5741 of 5 stars$14.69+1.2%$23.00+56.6%+25.4%$349.06M$281.54M10.65980Upcoming EarningsOSUROraSure Technologies4.5605 of 5 stars$4.17+2.5%$6.67+59.9%-20.1%$310.96M$405.47M11.58638Upcoming EarningsNews CoverageCERSCerus2.8657 of 5 stars$1.52-3.2%$3.63+138.5%+10.1%$281.66M$156.37M-13.82625News CoverageENOVEnovis2.955 of 5 stars$42.43+2.8%$67.00+57.9%-5.8%$2.37B$1.71B-25.566,550Upcoming EarningsIRTCiRhythm Technologies3.0679 of 5 stars$75.04+3.6%$111.60+48.7%-4.9%$2.34B$537.09M-15.442,000Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageSLNOSoleno Therapeutics4.2995 of 5 stars$55.86+1.5%$69.86+25.1%+132.7%$2.17BN/A-22.8930Upcoming EarningsCNMDCONMED4.8097 of 5 stars$70.37+3.1%$79.80+13.4%-28.7%$2.17B$1.24B16.714,000Earnings ReportAnalyst ForecastNews CoverageTNDMTandem Diabetes Care4.5349 of 5 stars$31.91+1.7%$55.13+72.8%+79.8%$2.09B$747.72M-15.272,400Upcoming EarningsPositive News Related Companies and Tools Related Companies ATRI Competitors CSII Competitors TCMD Competitors OSUR Competitors CERS Competitors ENOV Competitors IRTC Competitors SLNO Competitors CNMD Competitors TNDM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KIDS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
